| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Immunology,*
Pathology,
and
Biochemistry,
Roswell Park Cancer Institute,
Buffalo, New York
The question whether urokinase is expressed in human colon cancer by the cancer cells themselves or by surrounding stromal elements such as fibroblasts, macrophages, and leukocytes, which transfer the activator to the receptors of the cancer cells, has been a controversial one. In the present study 12 cases of colorectal cancer were investigated by immunohistochemical methods using three monoclonal antibodies of different specificity against urokinase. Cytoplasmic staining of strongly varying intensity was observed in all cases, with the antigen expressed most strongly in the apical and the basal regions of the cancer cells. In some cases, staining was also found in stromal elements surrounding the cancer glands. That the activator was indeed the product of the cancer cells was demonstrated by in situ hybridization using a uPA-cDNA probe, which detected the presence of uPA-mRNA in both the basal and the apical regions of the cancer cells. A monoclonal antibody against the receptor for uPA showed similar localization. These findings indicate that the activator is expressed by the cancer cells and is not recruited by them from stromal elements.
This article has been cited by other articles:
 |
|
 |
|
  T. C. Hurd, S. Sait, S. Kohga, J. Winston, M. Martinick, R. Saxena, H. Lankes, G. Markus, S. Harvey, and J. F. Gibbs Plasminogen Activator System Localization in 60 Cases of Ductal Carcinoma In Situ Ann. Surg. Oncol., November 1, 2007; 14(11): 3117 - 3124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Harvey, T. C. Hurd, G. Markus, M. I. Martinick, R. M. Penetrante, D. Tan, P. Venkataraman, N. DeSouza, S. N. J. Sait, D. L. Driscoll, et al. Evaluation of Urinary Plasminogen Activator, Its Receptor, Matrix Metalloproteinase-9, and von Willebrand Factor in Pancreatic Cancer Clin. Cancer Res., October 15, 2003; 9(13): 4935 - 4943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rosmann, D. Hahn, D. Lottaz, M.-N. Kruse, W. Stocker, and E. E. Sterchi Activation of Human Meprin-alpha in a Cell Culture Model of Colorectal Cancer Is Triggered by the Plasminogen-activating System J. Biol. Chem., October 18, 2002; 277(43): 40650 - 40658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Emenaker, G. M. Calaf, D. Cox, M. D. Basson, and N. Qureshi Short-Chain Fatty Acids Inhibit Invasive Human Colon Cancer by Modulating uPA, TIMP-1, TIMP-2, Mutant p53, Bcl-2, Bax, p21 and PCNA Protein Expression in an In Vitro Cell Culture Model J. Nutr., November 1, 2001; 131(11): 3041S - 3046. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Friedmann, I. Vlodavsky, H. Aingorn, A. Aviv, T. Peretz, I. Pecker, and O. Pappo Expression of Heparanase in Normal, Dysplastic, and Neoplastic Human Colonic Mucosa and Stroma : Evidence for Its Role in Colonic Tumorigenesis Am. J. Pathol., October 1, 2000; 157(4): 1167 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Khatib, G. Siegfried, A. Prat, J. Luis, M. Chretien, P. Metrakos, and N. G. Seidah Inhibition of Proprotein Convertases Is Associated with Loss of Growth and Tumorigenicity of HT-29 Human Colon Carcinoma Cells. IMPORTANCE OF INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) RECEPTOR PROCESSING IN IGF-1-MEDIATED FUNCTIONS J. Biol. Chem., August 10, 2001; 276(33): 30686 - 30693. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
